Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04236908 · ClinicalTrials.gov registry record · NA
Accessible Acupuncture for the Warrior With Acute Low Back Pain
A NA study, sponsored by David Moss.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
NCT04236908 is a NA study that has completed, run by David Moss. The registered enrollment target is 276 participants.
The verdict
NCT04236908, a NA study, has completed, sponsored by David Moss.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
Study Summary
The objective of this study is to determine if auricular acupuncture and/or the acupuncture point governor vessel 26 (GV26) with manual tonification is superior to conservative management (NSAIDs) at reducing acute low back pain (less than 4 weeks in duration).
Interventions
- DRUG NSAIDS
- DEVICE Battlefield Acupuncture
- DEVICE GV26 with manual tonification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2025-12-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04236908
The ClinicalTrials.gov registry entry for NCT04236908 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David Moss, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which NSAIDS is the first listed.
NCT04236908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04236908 about?
NCT04236908 is a clinical study titled "Accessible Acupuncture for the Warrior With Acute Low Back Pain". The objective of this study is to determine if auricular acupuncture and/or the acupuncture point governor vessel 26 (GV26) with manual tonification is superior to conservative management (NSAIDs) at reducing acute low back pain (less than 4 weeks in duration).
What is the current status of trial NCT04236908?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2020-08-25. Estimated completion is 2025-12-09.
What interventions are being tested in trial NCT04236908?
The interventions under investigation include: NSAIDS (DRUG), Battlefield Acupuncture (DEVICE), GV26 with manual tonification (DEVICE).
Who is sponsoring clinical trial NCT04236908?
This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.